Market Access Views & Analysis

Views & Analysis

Collaboration can ensure access to life-changing innovation

As a pioneering risk sharing scheme has shown, new medications can be the catalyst for a whole new care infrastructure.

Views & Analysis

A payer’s perspective on value-based contracting (VBC)

What payer wouldn’t want to ensure that they pay for value when buying drugs?

Views & Analysis

Paying for value: US state of play

Drug pricing in the US is a perennial topic, which is no surprise given the the US spends more per capita on prescription medicines than any other country.

Views & Analysis

When knowledge drives results: the impact of a winning data ...

Having an effective clinical trial data strategy in place can make the difference between success and an expensive failure for a pharma company.

Views & Analysis

UK’s drug supply contingency plan for hard Brexit

The UK government has issued several documents to help businesses in planning for the eventuality of a no-deal Brexit, but the UK’s Brexit Health Alliance says “the guidance is a first step

Views & Analysis